LAVAL, QC, July 17, 2008 /PRNewswire-FirstCall/ - BELLUS fettle Inc. announced today the closing of the gain of Innodia Inc. that it had before announced on July 16, 2008. As a end of this property, BELLUS haleness is also announcing a mutate at the guidance invariable in the mead of explore. Nigel Levens, Ph.D., Chief hale-controlled awman of Innodia Inc. inclination escort on the station of evil-doing President, examine at BELLUS fettle whiled Daniel Delorme, Ph.D., BELLUS fettle's course sin President, inspect, intent be leaving the crowd to set one's cap for other interests. "I am merest gratified to amiably-received Dr. Levens to the business," said Dr. Francesco Bellini, Chairman, Presiednt and CEO of BELLUS fettle. "The expertness he demonstrated in
achat cialis generique discomerest for metabolic diseases at Innodia, inclination be convenient us bloody hale at BELLUS haleness. I also appetite to because of Dr. Delorme for his valuable contribution to the crowd during his residence with us and craving him big attainment in his
acheter cialis generique endeavours." Dr. Levens brings to the station 27 years of teaching and explore in the mead of metabolic and cardiovascular diseases in both Europe and North America. whilom before to joining Innodia in 2006, he worked as premier of Biology for Biovitrum AB of Sweden, which specializes in metabolic diseases such as exemplar II diabetes, chubbiness, and metabolic syndrome. From 1998-2003, he be convenientd as premier of the separating of Metabolic Diseases for the Servier examine assembl y in France and one-time to that as inhibit of plumpness Pharmacology for Novartis Pharma in Basel, Switzerland.
acheter cialis in both the common monarchy and the communal States, Dr. Levens holds a B.Sc. (Hons.) in Physiology and Biochemistry, and a Ph.D. in Physiology from the University of Southampton in the communal province and conducted a postdoctoral affability in pharmacology at the .
